Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, is proud to announce key milestones achieved throughout 2024, underscoring a year defined by accelerated growth, ...
Droperidol was a first-line, highly effective agent for the treatment of PONV for over 30 years. It has the most postmarketing surveillance data of any of the currently used antiemetic agents.
Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy characterized by high risks of sustained ventricular tachycardia (sVT) and sudden cardiac death. Identifying patients ...
A cardiac surgeon using stem cells to test the effects of radiation as a treatment for ventricular tachycardia is the latest winner of a prestigious award at the McGill University Health Centre (MUHC) ...
A 62-year-old patient, with no prior medical history, was presented with ventricular tachycardia and was ultimately diagnosed with MINOCA after extensive investigation. The underlying cause of her ...
1 Department of Cardiology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China 2 Department of Emergency, Shenzhen Second People's Hospital, The ...